SK279276B6 - Farmaceutická kompozícia na liečenie príznakov vul - Google Patents

Farmaceutická kompozícia na liečenie príznakov vul Download PDF

Info

Publication number
SK279276B6
SK279276B6 SK77-95A SK7795A SK279276B6 SK 279276 B6 SK279276 B6 SK 279276B6 SK 7795 A SK7795 A SK 7795A SK 279276 B6 SK279276 B6 SK 279276B6
Authority
SK
Slovakia
Prior art keywords
polyoxyethylene glycol
weight
percent
treatment
lactose
Prior art date
Application number
SK77-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK7795A3 (en
Inventor
Gy�Rgy Hangay
G�Born� Ol�H
Edit T�Kos
Gy�Rgy V�Mos
Ern� M�H�Sz
Ern�N� M�H�Sz
Original Assignee
Vepex Kft.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vepex Kft. filed Critical Vepex Kft.
Publication of SK7795A3 publication Critical patent/SK7795A3/sk
Publication of SK279276B6 publication Critical patent/SK279276B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK77-95A 1992-07-22 1993-03-18 Farmaceutická kompozícia na liečenie príznakov vul SK279276B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9202398A HU212426B (en) 1992-07-22 1992-07-22 Process for producing bioactive pharmaceutical compositions
PCT/HU1993/000016 WO1994002148A1 (en) 1992-07-22 1993-03-18 Novel bioactive compositions, preparation and use thereof

Publications (2)

Publication Number Publication Date
SK7795A3 SK7795A3 (en) 1995-07-11
SK279276B6 true SK279276B6 (sk) 1998-09-09

Family

ID=10982190

Family Applications (1)

Application Number Title Priority Date Filing Date
SK77-95A SK279276B6 (sk) 1992-07-22 1993-03-18 Farmaceutická kompozícia na liečenie príznakov vul

Country Status (18)

Country Link
US (1) US5622927A (ru)
EP (1) EP0651641B1 (ru)
JP (1) JPH08501533A (ru)
KR (1) KR950702421A (ru)
AT (1) ATE170752T1 (ru)
AU (1) AU688260B2 (ru)
BG (1) BG62036B1 (ru)
CA (1) CA2140630A1 (ru)
CZ (1) CZ283011B6 (ru)
DE (1) DE69320968T2 (ru)
FI (1) FI950290A (ru)
HU (1) HU212426B (ru)
NZ (1) NZ251424A (ru)
PL (1) PL171031B1 (ru)
RO (1) RO111735B1 (ru)
RU (1) RU2117479C1 (ru)
SK (1) SK279276B6 (ru)
WO (1) WO1994002148A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1062111C (zh) * 1995-12-06 2001-02-21 李启荣 杂交水稻制种花期花时调节剂
US5750122A (en) * 1996-01-16 1998-05-12 The Procter & Gamble Company Compositions for treating hair or skin
CN1120000C (zh) * 1997-11-24 2003-09-03 曾忠铭 刺激阴道革兰氏阳性杆菌生长、增强阴道酸度的药剂和其用途
US6964949B2 (en) 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
US7205320B2 (en) * 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
ITMI20010913A1 (it) * 2001-05-04 2002-11-04 Univ Pavia Composizioni a rilascio controllato di acido lattico a livello vaginale
US6589216B1 (en) 2002-02-20 2003-07-08 Abbott Research Group, Inc. Vaginal douches, vaginal douche applicators and methods of vaginal douching
US7270653B2 (en) * 2002-02-20 2007-09-18 Abbott Research Group Methods of treating abnormal biological conditions using metal oxides
US8118789B2 (en) * 2002-02-20 2012-02-21 Abbott Research Group, Inc. Deodorizer devices and systems for controlling perspiration-related body odor
US20050271746A1 (en) * 2004-05-18 2005-12-08 Abbott Chun L Topical treatments for abnormal biological conditions and method of topically treating such conditions
JP4807972B2 (ja) * 2005-06-01 2011-11-02 株式会社池田模範堂 皮膚外用剤
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
WO2011132191A1 (en) 2010-04-21 2011-10-27 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
GB202018068D0 (en) * 2020-11-17 2020-12-30 Ucl Business Ltd Pharmaceutical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35991B1 (en) * 1971-01-22 1976-07-21 Comprehensive Pharmaceuticals Improvements in or relating to the treatment of diseases of the skin and mucosa
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
US4393066A (en) * 1981-06-05 1983-07-12 Garrett David M Method for treatment of herpetic lesions
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4665069A (en) * 1985-04-02 1987-05-12 Barnett Rosenberg Analgesic composition and method of relieving pain
WO1988004927A1 (en) * 1986-12-31 1988-07-14 Davirand, Inc. Compositions and formulations containing folic acid, method of treating tissue with folic acid and method for preparing compositions and formulations of folic acid
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface

Also Published As

Publication number Publication date
FI950290A0 (fi) 1995-01-23
KR950702421A (ko) 1995-07-29
WO1994002148A1 (en) 1994-02-03
AU688260B2 (en) 1998-03-12
HUT64840A (en) 1994-03-28
PL307256A1 (en) 1995-05-15
HU9202398D0 (en) 1992-10-28
BG62036B1 (bg) 1999-01-29
DE69320968T2 (de) 1999-04-15
RO111735B1 (ro) 1997-01-30
CZ283011B6 (cs) 1997-12-17
JPH08501533A (ja) 1996-02-20
EP0651641B1 (en) 1998-09-09
ATE170752T1 (de) 1998-09-15
CZ15395A3 (en) 1995-09-13
PL171031B1 (pl) 1997-02-28
EP0651641A1 (en) 1995-05-10
RU2117479C1 (ru) 1998-08-20
FI950290A (fi) 1995-01-23
CA2140630A1 (en) 1994-02-03
NZ251424A (en) 1997-06-24
DE69320968D1 (de) 1998-10-15
SK7795A3 (en) 1995-07-11
AU3903193A (en) 1994-02-14
US5622927A (en) 1997-04-22
BG99360A (bg) 1995-12-29
HU212426B (en) 1996-06-28

Similar Documents

Publication Publication Date Title
DE60032543T2 (de) Topisch verabreichbare Zinkzusammensetzungen
SK279276B6 (sk) Farmaceutická kompozícia na liečenie príznakov vul
US4424232A (en) Treatment of herpes simplex
DE69327642T2 (de) Verfahren zur behandlung von viralen infectionen
MX2007015074A (es) Formulaciones que contienen xiloglucano mucoadhesivo util en dispositivos medicos y en formulaciones farmaceuticas.
DE69506197T2 (de) Verwendung eines Ascorbyl-tocopherylphosphats zur Herstellung eines Arzneimittels zur Behandlung der Pankreatitis
EP4009977A2 (en) Compositions and methods for the treatment of estrogen-dependent disorders
US4957734A (en) Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
JPH06263644A (ja) リチウム治療剤
JP2000247893A (ja) 抗菌剤、入浴剤組成物及び皮膚洗浄剤組成物
JPS6241645B2 (ru)
DE60123464T2 (de) Zusammensetzung aus natrium, kalium, calcium und magnesium
US7262170B2 (en) Pharmaceutical composition for reducing vaginal acidity and treatment of vaginitis, and the use thereof
RU2517217C1 (ru) Средство для профилактики синдрома хронической усталости у мужчин
JPH04334321A (ja) 皮膚炎症予防剤
DE3701497A1 (de) Arzneimittel, enthaltend lokalanaesthetika und nukleoside sowie dessen verwendung zur behandlung von muskelverletzungen
RU2055579C1 (ru) Препарат для профилактики и лечения эндометритов у коров
JP2828185B2 (ja) 浴用剤組成物
CA1304687C (en) Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage
JP2002332237A (ja) 皮膚外用剤
US3034960A (en) Vaginal composition containing 9-aminoacridine undecylenate and n-myristyl-3-hydroxybutylamine hydrochloride
SU1659054A1 (ru) МЕСТНОЕ ПРОТИВОВОСПАЛИТЕЛЬНОЕ СРЕДСТВО "АЛОРОМ" 2
AT407483B (de) Veterinärmedizinisches mittel zum verabreichen von kalzium
RU2210367C2 (ru) Ранозаживляющее средство - "мазь тиотриазолина"
FR2518405A1 (fr) Melange de cromoglycate de sodium et de xylometazoline et procede pour le preparer